Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia
Authors:
- 18 October 2018
- journal article
- research article
- Published by Taylor & Francis in Autophagy
- Vol. 15 (3) , 493-509
Abstract
Mounting attention has been focused on defects in macroautophagy/autophagy and the autophagy-lysosomal pathway (ALP) in cerebral ischemia. TFEB (transcription factor EB)-mediated induction of ALP has been recently considered as the common mechanism in ameliorating the pathological lesion of myocardial ischemia and neurodegenerative diseases. Here we explored the vital role of TFEB in permanent middle cerebral artery occlusion (pMCAO)-mediated dysfunction of ALP and ischemic insult in rats. The results showed that ALP function was first enhanced in the early stage of the ischemic process, especially in neurons of the cortex, and this was accompanied by increased TFEB expression and translocation to the nucleus, which was mediated at least in part through activation by PPP3/calcineurin. At the later stages of ischemia, a gradual decrease in the level of nuclear TFEB was coupled with a progressive decline in lysosomal activity, accumulation of autophagosomes and autophagy substrates, and exacerbation of the ischemic injury. Notably, neuron-specific overexpression of TFEB significantly enhanced ALP function and rescued the ischemic damage, starting as early as 6 h and even lasting to 48 h after ischemia. Furthermore, neuron-specific knockdown of TFEB markedly reversed the activation of ALP and further aggravated the neurological deficits and ischemic outcome at the early stage of pMCAO. These results highlight neuronal-targeted TFEB as one of the key players in the pMCAO-mediated dysfunction of ALP and ischemic injury, and identify TFEB as a promising target for therapies aimed at neuroprotection in cerebral ischemia. Abbreviations: AAV, adeno-associated virus; AIF1/IBA1, allograft inflammatory factor 1; ALP, autophagy-lysosomal pathway; CQ, chloroquine; CTSB, cathepsin B; CTSD, cathepsin D; CsA, cyclosporin A; GFAP, glial fibrillary acidic protein; LAMP, lysosomal-associated membrane protein; LC3, microtubule-associated protein 1 light chain 3; MAP2, microtubule-associated protein 2; mNSS, modified Neurological Severity Score; MTOR, mechanistic target of rapamycin kinase; OGD, oxygen and glucose deprivation; pMCAO, permanent middle cerebral artery occlusion; RBFOX3/NeuN, RNA binding fox-1 homolog 3; SQSTM1, sequestosome1; TFEB, transcription factor EB; TTC, 2,3,5-triphenyltetrazolium chloride.Keywords
Funding Information
- Liaoning BaiQianWan Talents Program (2014921036)
This publication has 57 references indexed in Scilit:
- TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicityProceedings of the National Academy of Sciences, 2013
- Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte deathAutophagy, 2012
- Regulation of TFEB and V‐ATPases by mTORC1The EMBO Journal, 2011
- GSK-3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injuryBiochemical and Biophysical Research Communications, 2011
- TFEB Links Autophagy to Lysosomal BiogenesisScience, 2011
- Autophagy and protein aggregation after brain ischemiaJournal of Neurochemistry, 2010
- Inhibition of nuclear factor-κB by 6-O-acetyl shanzhiside methyl ester protects brain against injury in a rat model of ischemia and reperfusionJournal of Neuroinflammation, 2010
- Widespread cortical expression of MANF by AAV serotype 7: Localization and protection against ischemic brain injuryExperimental Neurology, 2010
- Mammalian autophagy: core molecular machinery and signaling regulationCurrent Opinion in Cell Biology, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010